
SOPHiA GENETICS Prices $50 Million Public Offering
SOPHiA GENETICS is raising $50 million through a public offering of 10,526,000 ordinary shares, priced at $4.75 each. The Nasdaq-listed healthcare technology firm, known for its AI-driven precision medicine platform, expects to close the transaction on June 18, 2026, pending standard closing requirements.

























